Breaking News Instant updates and real-time market news.

MTH

Meritage Homes

$45.00

-0.1 (-0.22%)

07:19
03/20/18
03/20
07:19
03/20/18
07:19

Meritage Homes initiated with an Outperform at Wedbush

Wedbush analyst Jay McCanless started Meritage Homes with an Outperform rating and $55 price target, noting that it is transforming itself into a company focused on the lower price bands instead of higher price bands.

MTH Meritage Homes
$45.00

-0.1 (-0.22%)

02/02/18
LEHM
02/02/18
UPGRADE
LEHM
Equal Weight
Meritage Homes upgraded to Equal Weight from Underweight at Barclays
02/02/18
LEHM
02/02/18
UPGRADE
Target $50
LEHM
Equal Weight
Meritage Homes upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Michael Dahl upgraded Meritage Homes to Equal Weight and raised his price target for the shares to $50 from $49. The shift toward entry-level and increased spec building is driving a greater acceleration in sales pace than expected, Dahl tells investors in a research note. He believes this overcomes the near-term lack of community count growth.
02/14/18
BOFA
02/14/18
UPGRADE
Target $55
BOFA
Neutral
Meritage Homes upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst John Lovallo upgraded Meritage Homes to Neutral and maintained a $55 price target due to the recent pullback in shares and improving execution.
03/07/18
JPMS
03/07/18
UPGRADE
Target $58
JPMS
Overweight
Meritage Homes upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Rehaut upgraded Meritage Homes to Overweight with an unchanged price target of $58. The analyst views the current valuation as attractive and expects "continued solid improvement" in the company's Southeast operations following challenges over the last 12-18 months.

TODAY'S FREE FLY STORIES

AMGN

Amgen

$171.91

-2.75 (-1.57%)

08:15
04/25/18
04/25
08:15
04/25/18
08:15
Recommendations
Amgen analyst commentary  »

Amgen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

  • 22

    May

  • 28

    May

ZLAB

Zai Lab

$18.06

-2.74 (-13.17%)

08:14
04/25/18
04/25
08:14
04/25/18
08:14
Hot Stocks
Zai Lab, Entasis announce license agreement for ETX2514 in Asia-Pacific region »

Entasis Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Wynn Resorts sees opening Boston Harbor project in mid-2019 »

With its earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Dare Bioscience, Juniper emter into exclusive worldwide license agreement »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Wynn Resorts CEO says Boston project not for sale »

Wynn Resorts CEO Matt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Twitter CEO says soliciting external experts to improve health of service »

CEO Jack Dorsey said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

AVXS

AveXis

$210.76

0.77 (0.37%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Hot Stocks
AveXis announces first patient dosed in Phase 3 trial of AVXS-101 »

AveXis announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

PHM

PulteGroup

$29.66

0.84 (2.91%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

HESM

Hess Midstream Partners

$19.49

-0.92 (-4.51%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Earnings
Hess Midstream Partners reaffirms FY18 net income view $335M-$360M »

Reaffirms FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CUE

Cue Biopharma

$13.45

-0.03 (-0.22%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Hot Stocks
Cue Biopharma appoints Anish Suri, Ph.D. as Chief Scientific Officer »

Cue Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$201.16

-14.855 (-6.88%)

08:10
04/25/18
04/25
08:10
04/25/18
08:10
Recommendations
3M analyst commentary  »

3M price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 18

    May

  • 30

    May

CEMI

Chembio Diagnostics

$7.80

-0.05 (-0.64%)

08:09
04/25/18
04/25
08:09
04/25/18
08:09
Hot Stocks
Chembio Diagnostics, LumiraDx enter collaboration for POC diagnostic tests »

Chembio Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 29

    May

EW

Edwards Lifesciences

$134.63

-2.59 (-1.89%)

08:09
04/25/18
04/25
08:09
04/25/18
08:09
Downgrade
Edwards Lifesciences rating change  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

INSE

Inspired Entertainment

$4.85

-0.4 (-7.62%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Inspired Entertainment signs games content agreement with Novomatic »

Inspired Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$42.96

-2.44 (-5.37%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Recommendations
Mercury Systems analyst commentary  »

Mercury Systems weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

HESM

Hess Midstream Partners

$19.49

-0.92 (-4.51%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Earnings
Hess Midstream Partners reports Q1 EPS 30c, consensus 28c »

Reports Q1 revenue $157M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Twitter: 'Privacy is a fundamental right for everyone we serve on our service' »

Comment taken from the Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Amphenol increases dividend 21% to 23c per share, approves $2B buyback plan »

Amphenol's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

LKFN

Lakeland Financial

$48.90

0.46 (0.95%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Earnings
Lakeland Financial reports Q1 EPS 71c, consensus 70c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$64.14

-0.25 (-0.39%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Periodicals
Icahn says Washington not for him, hasn't spoken with Trump in months »

"Neither I nor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$38.62

0.18 (0.47%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Hot Stocks
Hologic: FDA grants premarket approval for ThinPrep Integrated Imager »

Hologic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 08

    May

  • 12

    Jun

CPF

Central Pacific

$31.00

0.63 (2.07%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Earnings
Central Pacific reports Q1 EPS 48c, consensus 31c »

Reports Q1 NII $42.32M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:06
04/25/18
04/25
08:06
04/25/18
08:06
Earnings
Amphenol raises FY18 adjusted EPS view to $3.49-$3.55 from $3.39-$3.47 »

FY18 EPS consensus $3.46.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

, DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:05
04/25/18
04/25
08:05
04/25/18
08:05
Hot Stocks
Juniper Pharmaceuticals licenses intravaginal ring platform to Dare Bioscience »

Juniper Pharmaceuticals…

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$162.87

-2.38 (-1.44%)

08:05
04/25/18
04/25
08:05
04/25/18
08:05
Conference/Events
President Trump to meet with Apple CEO Cook »

The meeting between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.